Norvasc and Ingrowing nail - a phase IV clinical study of FDA data

Summary:

Ingrowing nail is found among people who take Norvasc, especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Norvasc and have Ingrowing nail. It is created by eHealthMe based on reports of 128,409 people who have side effects when taking Norvasc from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

128,409 people reported to have side effects when taking Norvasc.
Among them, 77 people (0.06%) have Ingrowing nail.

What is Norvasc?

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 131,576 Norvasc users for its effectiveness, alternative drugs and more.

What is Ingrowing nail?

Ingrowing nail is found to be associated with 816 drugs and 386 conditions by eHealthMe.

Number of Norvasc and Ingrowing nail reports submitted per year:

Time on Norvasc when people have Ingrowing nail *:

Gender of people who have Ingrowing nail when taking Norvasc *:

female: 88.16 %
male: 11.84 %

Age of people who have Ingrowing nail when taking Norvasc *:

Common drugs people take besides Norvasc *:

Common side effects people have besides Ingrowing nail *:

Urinary Tract Infection: 41 people, 53.25%
Weight Decreased: 34 people, 44.16%
Burning Sensation: 32 people, 41.56%
Loss Of Consciousness: 30 people, 38.96%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 30 people, 38.96%
Dizziness: 28 people, 36.36%
Headache (pain in head): 26 people, 33.77%
Insomnia (sleeplessness): 26 people, 33.77%
Diarrhea: 25 people, 32.47%
Abdominal Distension: 24 people, 31.17%

Common conditions people have *:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 28 people, 36.36%
Anaesthesia: 13 people, 16.88%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 8 people, 10.39%
Osteoporosis (bones weak and more likely to break): 6 people, 7.79%
Renal Disorder (kidney disease): 6 people, 7.79%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 7.79%
Skin Blushing/flushing (a sudden reddening of the face, neck): 5 people, 6.49%
High Blood Cholesterol: 5 people, 6.49%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 6.49%
Heart Rate Irregular: 5 people, 6.49%

* Approximation only. Some reports may have incomplete information.

Do you take Norvasc and have Ingrowing nail?

Check whether Ingrowing nail is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Ingrowing nail and when was it recovered:

Ingrowing nail in Norvasc

Expand to all the drugs that have ingredients of amlodipine besylate:

Ingrowing nail and drugs with ingredients of amlodipine besylate

Alternative drugs to, pros and cons of Norvasc:

Norvasc (131,576 reports)

Common Norvasc side effects:

High blood pressure: 9,886 reports
Fatigue (feeling of tiredness): 7,134 reports
Weakness: 7,052 reports
Breathing difficulty: 7,011 reports
Pain: 6,152 reports
Diarrhea: 6,053 reports

Browse all side effects of Norvasc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ingrowing nail treatments and more:

Ingrowing nail (3,106 reports)

COVID vaccines that are related to Ingrowing nail:

Common drugs associated with Ingrowing nail:

All the drugs that are associated with Ingrowing nail:

Ingrowing nail (816 drugs)

Common conditions associated with Ingrowing nail:

Rheumatoid arthritis: 339 reports
High blood pressure: 171 reports
Osteoporosis: 167 reports
Psoriasis: 162 reports

All the conditions that are associated with Ingrowing nail:

Ingrowing nail (386 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Norvasc) and Norvasc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.